IL6 and lung adenocarcinoma: IL-6 is a pro-inflammatory cytokine produced in the TME by stromal, immune, and tumor cells and has been associated with tumor pathogenesis, progression, and treatment resistance in lung adenocarcinoma [24,25,26].